6
Add it to the list of offenses: Pfizer pulls 50% of its Lyme vaccine clinical trial participants for good clinical practice (GCP) violations at US trial sites. 2/3rds of the trial subjects were supposed to come from the US. Still aim for approval in 2025. (www.fiercebiotech.com)
posted ago by GetsTheNogginJoggin ago by GetsTheNogginJoggin +6 / -0
Pfizer pulls 50% of people from phase 3 Lyme disease study for GCP violations at US trial sites
Pfizer and Valneva’s phase 3 Lyme disease vaccine clinical trial has gone badly wrong. | Pfizer and Valneva’s phase 3 Lyme disease vaccine clinical trial has gone badly wrong. After discovering good clinical practice violations at some trial sites, the par...
www.fiercebiotech.com
1 comment
1 comment share save hide report block hide replies